Ways and Means Committee, Finance Committee, Health Subcommittee, Energy and Commerce Committee
Introduced
In Committee
On Floor
Passed Chamber
Enacted
Expanding Oversight of Opioid Prescribing and Payment Act of 2018 (Sec. 2) This bill requires the Medicare Payment Advisory Commission to report to Congress on: (1) how Medicare pays for opioid and non-opioid pain management treatments in inpatient and outpatient hospital settings; (2) current incentives for prescribing opioid and non-opioid treatments under Medicare inpatient and outpatient prospective payment systems, along with recommendations to address any identified adverse incentives; and (3) how opioid use is currently tracked and monitored through Medicare and any areas for improvement.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ordered to be Reported (Amended) by Voice Vote.
Committee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Health.
Placed on the Union Calendar, Calendar No. 592.
Committee on Energy and Commerce discharged.
Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-760, Part I.
Mr. Roskam moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H5264-5265)
DEBATE - The House proceeded with forty minutes of debate on H.R. 5723.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5264)
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5264)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Finance.
Introduced in House
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ordered to be Reported (Amended) by Voice Vote.
Committee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Health.
Placed on the Union Calendar, Calendar No. 592.
Committee on Energy and Commerce discharged.
Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-760, Part I.
Mr. Roskam moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H5264-5265)
DEBATE - The House proceeded with forty minutes of debate on H.R. 5723.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5264)
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5264)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Finance.
Congressional oversightDrug, alcohol, tobacco useDrug trafficking and controlled substancesHealth information and medical recordsHome and outpatient careHospital careMedicarePrescription drugs
Expanding Oversight of Opioid Prescribing and Payment Act of 2018
USA115th CongressHR-5723| House
| Updated: 6/20/2018
Expanding Oversight of Opioid Prescribing and Payment Act of 2018 (Sec. 2) This bill requires the Medicare Payment Advisory Commission to report to Congress on: (1) how Medicare pays for opioid and non-opioid pain management treatments in inpatient and outpatient hospital settings; (2) current incentives for prescribing opioid and non-opioid treatments under Medicare inpatient and outpatient prospective payment systems, along with recommendations to address any identified adverse incentives; and (3) how opioid use is currently tracked and monitored through Medicare and any areas for improvement.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ordered to be Reported (Amended) by Voice Vote.
Committee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Health.
Placed on the Union Calendar, Calendar No. 592.
Committee on Energy and Commerce discharged.
Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-760, Part I.
Mr. Roskam moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H5264-5265)
DEBATE - The House proceeded with forty minutes of debate on H.R. 5723.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5264)
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5264)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Finance.
Introduced in House
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ordered to be Reported (Amended) by Voice Vote.
Committee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Health.
Placed on the Union Calendar, Calendar No. 592.
Committee on Energy and Commerce discharged.
Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-760, Part I.
Mr. Roskam moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H5264-5265)
DEBATE - The House proceeded with forty minutes of debate on H.R. 5723.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5264)
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5264)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Finance.
Congressional oversightDrug, alcohol, tobacco useDrug trafficking and controlled substancesHealth information and medical recordsHome and outpatient careHospital careMedicarePrescription drugs